Pengaruh Influence of Giving Ferrum (Fe) Tablet with Hemoglobin Levels in Pregnant 3rd Trimester Mother
Anemia has a role as a cause of high maternal and infant mortality. According to Riskesdas in 2018 the prevalence of pregnancy anemia is relatively high, which is 48.9%. From the data in 2018, the highest number of pregnant women who have anemia at the age of 15-24 years is 84.6%, age 25-34 years is 33.7%, age 35-44 years is 33.6%, and age 45 -54 years at 24%. For the treatment, iron tablets are given for 90 days. The results of the 2018 Riskesdas survey the coverage of Fe tablets for pregnant women in Karanganyar district has reached 100%, but the incidence of anemia in pregnant women is still high. The purpose of this study was to determine the effect of consumption of iron tablets (Fe) on hemoglobin (Hb) levels in pregnant women at the Kusumahati Jaten Clinic. The sample used saturated samples and obtained a sample of 30 people. Data collection used guided interviews in third trimester pregnant women and Kusumahati Jaten clinic reports about examining the amount of Fe tablets given to respondents and Hb levels that were first examined before consuming Fe tablets. In addition, direct measurements were taken of the mother's Hb with an Easy Touch tool. Based on the results of the research and discussion that has been described, it can be concluded that there is an influence between iron (Fe) intake and the increase in hemoglobin (Hb) levels in pregnant women in the Kusumahati Jaten clinic, Karanganyar in 2018. in the low category as many as 19 respondents (63%) and the Hb value on the second stage examination showed in the high category as many as 23 respondents (77%). From the results of this study it is expected that pregnant women consume iron tablets according to the prescribed amount.